Corneal Opacity: Cell Biological Determinants of the Transition From Transparency to Transient Haze to Scarring Fibrosis, and Resolution, After Injury.
Wilson SE, Sampaio LP, Shiju TM, Hilgert GSL, de Oliveira RC.
Invest Ophthalmol Vis Sci. 2022 Jan 3;63(1):22. doi: 10.1167/iovs.63.1.22.
PMID:35044454
Topical Losartan for Treating Corneal Fibrosis (Haze): First Clinical Experience.
Pereira-Souza AL, Ambrósio R Jr, Bandeira F, Salomão MQ, Souza Lima A, Wilson SE.